- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02473991
Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The investigator will make certain that the appropriate informed consent process is in place to ensure that potential research subjects, or their authorized representatives, are fully informed about the nature and objectives of the study, the potential risk and benefits of study participation, and their right as research subjects.
All laboratory specimens, evaluation forms, reports, video recordings, and other records that leave the site will not include unique personal data to maintain subject confidentiality.
All patients provided an informed written consent after they were fully instructed about the investigation.The study was approved by ethical committee of Ain Shams University.
All recruited women were observed at the 1st trimester screening at antenatal clinic and assessed for baseline demographic and obstetric data including age, parity, body mass index (BMI) and past medical events. Smoking, alcohol and drug use were also determined.
At second and third trimester (15-20 and 30-34 weeks of gestation respectively), the maternal weight, weight gain, BMI, BMI gain and data of ultrasound examination were recorded. At the time of delivery after assessment of maternal weight as mentioned above, the birth weight (in grams), fetal sex, and mode of delivery were taken.
All pregnant women underwent ultrasound evaluation of placental thickness at the time of second trimester (15-20 weeks of gestation) as well as third trimester (30-34 weeks of gestation).
All sonographic examinations were performed trans-abdominal using a Medison X4 ultrasound machine Trans abdominal4.0 megahertz (MHz) probe at The Special Care Center for Fetus Unit at Ain Shams University Maternity Hospital.
The placental thickness was measured by placing the ultrasound transducer perpendicularly to the plane of the placenta, in the area of the cord insertion, near the mid-placental portion as described by Hoddick et al
Each evaluation was performed by one of two experienced sonographers of our hospital with minimum inter- and intra-observer variability.
After delivery, the placenta was weighed in grams as previously described by Azpurua et al.
Fetal weight (primary objective) and neonatal status and morbidity including baby Apgar scores, fetal distress or fetal death and admission to the neonatal intensive care unit were also determined. All the examinations and data recording were performed by two senior resident physicians.(secondary objective)
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Elabbasia
-
Cairo, Elabbasia, Egypten
- Ain Shams Faculty of Medicine
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- patient Aged between 18 and 45 years.
- singleton viable pregnancy.
- non scared uterus.
Exclusion Criteria:
- systemic illness (DM,Hypertension, renal disease, liver disease, sickle cell disease)
- known congenital fetal anomalies.
- multiple pregnancy.
- intra uterine fetal death.
- anatomical defect of pregnant uterus
- abnormally located placenta or placental anomalies
- morbid obesity
- missing records
- unwilling to incorporate in the study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fetal Weight (Fetal Weight at Birth)
Tidsramme: 9 months
|
Fetal weight (fetal weight at birth) (in grams)
|
9 months
|
|
Placental Thickness in Second Trimester
Tidsramme: 15-20 weeks of gestation
|
placental thickness measured in millimeter
|
15-20 weeks of gestation
|
|
Placental Thickness at 3rd Trimester
Tidsramme: 30-34 weeks of pregnancy
|
30-34 weeks of pregnancy
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Studieleder: AHMED MEKLED, Professor, Ain Shams University
- Studieleder: HAYTHAM SABAA, Lecturer, Ain Shams University
Publikationer og nyttige links
Generelle publikationer
- Azpurua H, Funai EF, Coraluzzi LM, Doherty LF, Sasson IE, Kliman M, Kliman HJ. Determination of placental weight using two-dimensional sonography and volumetric mathematic modeling. Am J Perinatol. 2010 Feb;27(2):151-5. doi: 10.1055/s-0029-1234034. Epub 2009 Aug 3.
- Hoddick WK, Mahony BS, Callen PW, Filly RA. Placental thickness. J Ultrasound Med. 1985 Sep;4(9):479-82. doi: 10.7863/jum.1985.4.9.479.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Master degree in Obs & gyn
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Graviditet
-
King's College Hospital NHS TrustEuropean Association for the Study of the LiverRekrutteringCirrhose, lever | HELLP syndrom | Intrahepatisk kolestase af graviditet | Graviditetssygdom | AFLP - Acute Fatty Lever of PregnancyDet Forenede Kongerige
Kliniske forsøg med ultrasound
-
ReCor Medical, Inc.RekrutteringHjerte-kar-sygdomme | Karsygdomme | Forhøjet blodtrykForenede Stater
-
Institute of Oncology LjubljanaAktiv, ikke rekrutterendeBrystkræft | AksellymfeknudemetastaseSlovenien
-
M.D. Anderson Cancer CenterRekrutteringRecidiverende parathyroidea-carcinomForenede Stater
-
Medical University of ViennaIkke rekrutterer endnuHjerte- og aortakirurgi | Venøs overbelastning | Væske genoplivning | Hjerteanæstesi
-
Fujian Medical UniversityIkke rekrutterer endnuLymfemetastase | Thyroidneoplasmer | Papillært skjoldbruskkirtelcarcinom | RET proto-oncogen-mutationKina
-
General Hospital of Ningxia Medical UniversityIkke rekrutterer endnuSkadelig virkning | Sikkerhed og effektivitet | ForundersøgelseKina
-
Resolve StrokeRekrutteringNeurologisk komplikation | Cerebral iskæmi | Neuro ICU | Subarachnoid blødning | Hjerneskader, karFrankrig
-
Sarasota Memorial Health Care SystemTilmelding efter invitationThyroid Nodule | Skjoldbruskkirtel nodulerForenede Stater
-
Cairo UniversityIkke rekrutterer endnu
-
ReCor Medical, Inc.RekrutteringForhøjet blodtrykØstrig, Schweiz, Tyskland, Belgien, Holland, Det Forenede Kongerige, Frankrig, Monaco, Spanien